# OnCo record ga68-dotatate (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ga68-dotatate/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ga68-dotatate" ;
  schema:name "Gallium-68 DOTATATE (and Cu-64 DOTATATE)"@en ;
  schema:description "The PET scan for neuroendocrine tumours that finds far more disease than older scans and confirms eligibility for lutetium radioligand therapy (the theranostic pair)."@en ;
  schema:url <https://onco.cc/drugs/ga68-dotatate/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Netspot>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Detectnet> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "diagnostic" ;
  onco:modality "PET radiotracer (somatostatin receptor ligand)" ;
  schema:alternateName "Netspot / Detectnet" ;
  onco:approval "US 2016: PET localisation of SSTR-positive neuroendocrine tumours (Ga-68 DOTATATE)", "US 2020: Same (Cu-64 DOTATATE)", "EU 2017: SomaKit TOC (Ga-68 DOTATOC)" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/small-intestinal-net/>, <https://onco.cc/cancers/pancreatic-net/>, <https://onco.cc/cancers/lung-net/> ;
  onco:technologies <https://onco.cc/technologies/sstr-pet/>, <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/technologies/prrt/>, <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:targets <https://onco.cc/targets/sstr2/> ;
  onco:companies <https://onco.cc/companies/novartis/>, <https://onco.cc/companies/curium/> ;
  onco:terms <https://onco.cc/terms/theranostics/>, <https://onco.cc/terms/prrt-term/> ;
  onco:trials <https://onco.cc/trials/nct04847505/>, <https://onco.cc/trials/nct05880394/> .